TY - JOUR AU - Fernandez-Sabe, N. AU - Carratala, J. AU - Roson, B. AU - Dorca, J. AU - Verdaguer, R. AU - Manresa, F. AU - Gudiol, F. PY - 2003 DA - 2003// TI - Community-acquired pneumonia in very elderly patients: causative organisms, clinical characteristics, and outcomes JO - Medicine VL - 82 ID - Fernandez-Sabe2003 ER - TY - JOUR AU - Kohno, S. AU - Imamura, Y. AU - Shindo, Y. AU - Seki, M. AU - Ishida, T. AU - Teramoto, S. AU - Kadota, J. AU - Tomono, K. AU - Watanabe, A. PY - 2013 DA - 2013// TI - Clinical practice guidelines for nursing- and healthcare-associated pneumonia (NHCAP) [complete translation] JO - Respir Investig VL - 51 UR - https://doi.org/10.1016/j.resinv.2012.11.001 DO - 10.1016/j.resinv.2012.11.001 ID - Kohno2013 ER - TY - JOUR AU - Teramoto, S. AU - Fukuchi, Y. AU - Sasaki, H. AU - Sato, K. AU - Sekizawa, K. AU - Matsuse, T. PY - 2008 DA - 2008// TI - High incidence of aspiration pneumonia in community- and hospital-acquired pneumonia in hospitalized patients: a multicenter, prospective study in Japan JO - J Am Geriatr Soc VL - 56 UR - https://doi.org/10.1111/j.1532-5415.2008.01597.x DO - 10.1111/j.1532-5415.2008.01597.x ID - Teramoto2008 ER - TY - JOUR AU - Bartlett, J. G. AU - Gorbach, S. L. AU - Finegold, S. M. PY - 1974 DA - 1974// TI - The bacteriology of aspiration pneumonia JO - Am J Med VL - 56 UR - https://doi.org/10.1016/0002-9343(74)90598-1 DO - 10.1016/0002-9343(74)90598-1 ID - Bartlett1974 ER - TY - JOUR AU - Lode, H. PY - 1988 DA - 1988// TI - Microbiological and clinical aspects of aspiration pneumonia JO - J Antimicrob Chemother VL - 21 UR - https://doi.org/10.1093/jac/21.suppl_C.83 DO - 10.1093/jac/21.suppl_C.83 ID - Lode1988 ER - TY - JOUR AU - El-Solh, A. A. AU - Pietrantoni, C. AU - Bhat, A. AU - Aquilina, A. T. AU - Okada, M. AU - Grover, V. AU - Gifford, N. PY - 2003 DA - 2003// TI - Microbiology of severe aspiration pneumonia in institutionalized elderly JO - Am J Rrespir Crit Care Med VL - 167 UR - https://doi.org/10.1164/rccm.200212-1543OC DO - 10.1164/rccm.200212-1543OC ID - El-Solh2003 ER - TY - STD TI - Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Rrespir Crit Care Med. 2005, 171 (4): 388-416. 10.1164/rccm.200405-644ST. ID - ref7 ER - TY - JOUR AU - Pfaller, M. A. AU - Farrell, D. J. AU - Sader, H. S. AU - Jones, R. N. PY - 2012 DA - 2012// TI - AWARE Ceftaroline Surveillance Program (2008–2010): trends in resistance patterns among Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States JO - Clin Infect Dis VL - 55 UR - https://doi.org/10.1093/cid/cis561 DO - 10.1093/cid/cis561 ID - Pfaller2012 ER - TY - JOUR AU - Sefton, A. M. AU - Maskell, J. P. AU - Beighton, D. AU - Whiley, A. AU - Shain, H. AU - Foyle, D. AU - Smith, S. R. AU - Smales, F. C. AU - Williams, J. D. PY - 1996 DA - 1996// TI - Azithromycin in the treatment of periodontal disease. Effect on microbial flora JO - J Clin Periodontol VL - 23 UR - https://doi.org/10.1111/j.1600-051X.1996.tb00527.x DO - 10.1111/j.1600-051X.1996.tb00527.x ID - Sefton1996 ER - TY - JOUR AU - Barlow, G. AU - Nathwani, D. AU - Davey, P. PY - 2007 DA - 2007// TI - The CURB65 pneumonia severity score outperforms generic sepsis and early warning scores in predicting mortality in community-acquired pneumonia JO - Thorax VL - 62 UR - https://doi.org/10.1136/thx.2006.067371 DO - 10.1136/thx.2006.067371 ID - Barlow2007 ER - TY - JOUR AU - Lim, W. S. AU - van der Eerden, M. M. AU - Laing, R. AU - Boersma, W. G. AU - Karalus, N. AU - Town, G. I. AU - Lewis, S. A. AU - Macfarlane, J. T. PY - 2003 DA - 2003// TI - Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study JO - Thorax VL - 58 UR - https://doi.org/10.1136/thorax.58.5.377 DO - 10.1136/thorax.58.5.377 ID - Lim2003 ER - TY - JOUR AU - Miyashita, N. AU - Matsushima, T. AU - Oka, M. AU - Japanese Respiratory, S. PY - 2006 DA - 2006// TI - The JRS guidelines for the management of community-acquired pneumonia in adults: an update and new recommendations JO - Intern Med VL - 45 UR - https://doi.org/10.2169/internalmedicine.45.1691 DO - 10.2169/internalmedicine.45.1691 ID - Miyashita2006 ER - TY - JOUR AU - Weinstein, M. P. AU - Klugman, K. P. AU - Jones, R. N. PY - 2009 DA - 2009// TI - Rationale for revised penicillin susceptibility breakpoints versus Streptococcus pneumoniae: coping with antimicrobial susceptibility in an era of resistance JO - Clin Infect Dis VL - 48 UR - https://doi.org/10.1086/598975 DO - 10.1086/598975 ID - Weinstein2009 ER - TY - JOUR AU - Craig, W. A. PY - 1998 DA - 1998// TI - Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men JO - Clin Infect Dis VL - 26 UR - https://doi.org/10.1086/516284 DO - 10.1086/516284 ID - Craig1998 ER - TY - JOUR AU - Tice, A. D. AU - Rehm, S. J. AU - Dalovisio, J. R. AU - Bradley, J. S. AU - Martinelli, L. P. AU - Graham, D. R. AU - Gainer, R. B. AU - Kunkel, M. J. AU - Yancey, R. W. AU - Williams, D. N. PY - 2004 DA - 2004// TI - Practice guidelines for outpatient parenteral antimicrobial therapy. IDSA guidelines JO - Clin Infect Dis VL - 38 UR - https://doi.org/10.1086/420939 DO - 10.1086/420939 ID - Tice2004 ER - TY - JOUR AU - Berry, V. AU - Thorburn, C. E. AU - Knott, S. J. AU - Woodnutt, G. PY - 1998 DA - 1998// TI - Bacteriological efficacies of three macrolides compared with those of amoxicillin-clavulanate against Streptococcus pneumoniae and Haemophilus influenzae JO - Antimicrob Agents Chemother VL - 42 ID - Berry1998 ER - TY - JOUR AU - Pankey, G. A. AU - Sabath, L. D. PY - 2004 DA - 2004// TI - Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of Gram-positive bacterial infections JO - Clin Infect Dis VL - 38 UR - https://doi.org/10.1086/381972 DO - 10.1086/381972 ID - Pankey2004 ER - TY - JOUR AU - Bakker-Woudenberg, I. A. AU - van Vianen, W. AU - van Soolingen, D. AU - Verbrugh, H. A. AU - van Agtmael, M. A. PY - 2005 DA - 2005// TI - Antimycobacterial agents differ with respect to their bacteriostatic versus bactericidal activities in relation to time of exposure, mycobacterial growth phase, and their use in combination JO - Antimicrob Agents Chemother VL - 49 UR - https://doi.org/10.1128/AAC.49.6.2387-2398.2005 DO - 10.1128/AAC.49.6.2387-2398.2005 ID - Bakker-Woudenberg2005 ER - TY - JOUR AU - Restrepo, M. I. AU - Mortensen, E. M. AU - Waterer, G. W. AU - Wunderink, R. G. AU - Coalson, J. J. AU - Anzueto, A. PY - 2009 DA - 2009// TI - Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia JO - Eur Respir J VL - 33 UR - https://doi.org/10.1183/09031936.00054108 DO - 10.1183/09031936.00054108 ID - Restrepo2009 ER - TY - JOUR AU - Watanabe, A. AU - Yanagihara, K. AU - Matsumoto, T. AU - Kohno, S. AU - Aoki, N. AU - Oguri, T. AU - Sato, J. AU - Muratani, T. AU - Yagisawa, M. AU - Ogasawara, K. AU - Koashi, N. AU - Kozuki, T. AU - Komoto, A. AU - Takahashi, Y. AU - Tsuji, T. AU - Terada, M. AU - Nakanishi, K. AU - Hattori, R. AU - Hirako, Y. AU - Maruo, A. AU - Minamitani, S. AU - Morita, K. AU - Wakamura, T. AU - Sunakawa, K. AU - Hanaki, H. AU - Ohsaki, Y. AU - Honda, Y. AU - Sasaoka, S. AU - Takeda, H. AU - Ikeda, H. PY - 2012 DA - 2012// TI - Nationwide surveillance of bacterial respiratory pathogens conducted by the Survellance Committee of Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Clinical Microbiology in 2009: general view of the pathogens' antibacterial susceptibility JO - J Infect Chemother VL - 18 UR - https://doi.org/10.1007/s10156-012-0434-3 DO - 10.1007/s10156-012-0434-3 ID - Watanabe2012 ER - TY - JOUR AU - Kohno, S. AU - Tateda, K. AU - Kadota, J. I. AU - Fujita, J. AU - Niki, Y. AU - Watanabe, A. AU - Nagashima, M. PY - 2013 DA - 2013// TI - Contradiction between in vitro and clinical outcome: Intravenous followed by oral azithromycin therapy demonstrated clinical efficacy in macrolide-resistant pneumococcal pneumonia JO - J Infect Chemother VL - 20 UR - https://doi.org/10.1016/j.jiac.2013.10.010 DO - 10.1016/j.jiac.2013.10.010 ID - Kohno2013 ER - TY - JOUR AU - Chiu, L. M. AU - Menhinick, A. M. AU - Johnson, P. W. AU - Amsden, G. W. PY - 2002 DA - 2002// TI - Pharmacokinetics of intravenous azithromycin and ceftriaxone when administered alone and concurrently to healthy volunteers JO - J Antimicrob Chemother VL - 50 UR - https://doi.org/10.1093/jac/dkg003 DO - 10.1093/jac/dkg003 ID - Chiu2002 ER - TY - JOUR AU - Rodvold, K. A. AU - Danziger, L. H. AU - Gotfried, M. H. PY - 2003 DA - 2003// TI - Steady-state plasma and bronchopulmonary concentrations of intravenous levofloxacin and azithromycin in healthy adults JO - Antimicrob Agents Chemother VL - 47 UR - https://doi.org/10.1128/AAC.47.8.2450-2457.2003 DO - 10.1128/AAC.47.8.2450-2457.2003 ID - Rodvold2003 ER - TY - JOUR AU - Fukuda, Y. AU - Yanagihara, K. AU - Higashiyama, Y. AU - Miyazaki, Y. AU - Hirakata, Y. AU - Mukae, H. AU - Tomono, K. AU - Mizuta, Y. AU - Tsukamoto, K. AU - Kohno, S. PY - 2006 DA - 2006// TI - Effects of macrolides on pneumolysin of macrolide-resistant Streptococcus pneumoniae JO - Eur Respir J VL - 27 ID - Fukuda2006 ER - TY - JOUR AU - Zarogoulidis, P. AU - Papanas, N. AU - Kioumis, I. AU - Chatzaki, E. AU - Maltezos, E. AU - Zarogoulidis, K. PY - 2012 DA - 2012// TI - Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases JO - Eur J Clin Pharmacol VL - 68 UR - https://doi.org/10.1007/s00228-011-1161-x DO - 10.1007/s00228-011-1161-x ID - Zarogoulidis2012 ER -